Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer

BACKGROUND: Although the conversion of clinically used breast cancer biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) between primary tumors and metastatic lesions is well recognized, data on whether receptor conversion has an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Weipeng, Sun, Linlin, Dong, Guolei, Wang, Xiaorui, Jia, Yan, Tong, Zhongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111518/
https://www.ncbi.nlm.nih.gov/pubmed/33995598
http://dx.doi.org/10.1177/17588359211012982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111518/
https://www.ncbi.nlm.nih.gov/pubmed/33995598
http://dx.doi.org/10.1177/17588359211012982

Ejemplares similares